Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2021 Q4 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2021 Q4 - Results - Earnings Call Presentation
MERCK Kommanditgesellschaft auf Aktien press release (OTCPK:MKGAF): FY GAAP EPS of €7.03. Revenue of €19.68B (+12.3% Y/Y). For further details see: MERCK Kommanditgesellschaft auf Aktien GAAP EPS of €7.03, revenue of €19.68B
Palantir's stock has lost as much as 38% of its value this year and 57% from its November peak. The latest Palantir sell-off follows broader market declines that pushed the S&P 500 and tech-heavy Nasdaq 100 into correction territory last month. Markets have been extremely vola...
Quris signed an agreement with Merck KGaA (OTCPK:MKGAF) to assess Quris’ BioAI safety prediction platform, comparing it to traditional in vitro and in vivo approaches. Quris’ BioAI safety prediction platform introduces a unique concept, which integrates miniaturized human t...
Merck KGaA (OTCPK:MKGAF) announced organizational changes and a new operating model for its growth strategy. Existing Contract Development and Manufacturing Organization (CDMO) and Contract Testing services will be consolidated into one global fully integrated Life Science Services ...
Sutro Biopharma expects to report interim results from a phase 1 study using STRO-002 at KOL event on Wednesday Jan. 5, 2022, at 5 p.m. ET. Antibody Drug Conjugate STRO-002 is being developed for the treatment of patients with ovarian cancer and endometrial cancer. STRO-001 is ano...
Aerie Pharmaceuticals (NASDAQ:AERI) has named Raj Kannan, a former executive at Merck KGaA (OTCPK:MKGAF) (OTCPK:MKKGY), as the company’s new Chief Executive Officer effective Dec. 20. Raj, a 25-year veteran in leadership, will also join Aerie’s board as a director. Before joinin...
The revolutionary technology of synthetic biology is poised to make a profound impact on the way a vast array of products are manufactured, from lab-grown meat to cosmetics to biodegradable packaging. Like the internet revolution, companies that enable or effectively harness synthetic...
Isofol Medical has received the Fast Track Designation from the FDA for its lead asset, arfolitixorin, in the treatment of metastatic colorectal cancer ((mCRC)), the company said on Tuesday. Fast Track designation is offered by the FDA to accelerate the development and review of dru...
AEG, OTCQX:ALEAF, AMTX, AYRO, AZUL, BAM, BGRY, CAE, CELH, OTCQX:CRLBF, DCBO, OTCQX:EDVMF, GRWG, HUT, IMV, OTCPK:MKGAF, NICE, NVVE, OGN, PSFE, QSI, RSLS, RWLK, SBH, SPCB, SPH, STNG, STXS, THRY, TMDI, TPR, TXMD, UTZ, VNRX, WB, WIX, WWR, XNET, YETI For Seeking Alpha's full earnings season calend...
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...